ALFA Filings
Every announcement, straight from the exchange
Announcement type
Time
5 announcements
KMS Medisurgi Ltd reported revenue from operations of ₹5.6 Cr (-8.2% YoY) and net profit of ₹0 Cr for H2 FY26.
KMS Medisurgi Limited reported audited standalone financial results for the year ended March 31, 2026. The results include a qualified auditor's opinion regarding stock records and employee benefits.
KMS Medisurgi scheduled a board meeting for May 30, 2026, to approve annual audited financial results. Trading window remains closed until 48 hours post-announcement.
KMS Medisurgi Limited submitted a non-applicability declaration regarding corporate governance reports for the year ended March 31, 2026. As an SME-listed entity, the company is exempt from these specific SEBI LODR disclosure requirements under Regulation 15(2).
KMS Medisurgi Limited submitted a non-applicability disclosure regarding Related Party Transactions for the year ended March 31, 2026. The company is exempt under SEBI LODR Regulation 15(2) due to its listing on the BSE SME Platform and having paid-up capital and net worth below the specified regulatory thresholds.